Enveric Biosciences Inc vs Ford Motor Company — how do they compare? Enveric Biosciences Inc trades at $1.35 (market cap $5.32M), while Ford Motor Company trades at $14.18 (market cap $56.50B). The key difference: Ford Motor Company is far larger — about 10620.3× Enveric Biosciences Inc's market cap, and Ford Motor Company pays a 4.23% dividend while Enveric Biosciences Inc pays none. Which is the better fit depends on your goals.
| ENVB | F | |
|---|---|---|
Market Cap | $5.32M | $56.50B |
Sector | Health | Consumer Cyclical |
52-Week High | $17.40 | $17.44 |
52-Week Low | $1.28 | $10.82 |
Enterprise Value | $408.82K | $185.53B |
Dividend Yield | — | 4.23% |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Ford (F) trades at $13.93, up 0.44% on the day, with a neutral technical outlook and mixed fundamental signals. The company reported a net loss of $8.18 billion in 2025 despite revenue growth to $187.27 billion, reflecting margin pressure. Recent news highlights labor agreements, EV initiatives, and a 4%+ dividend yield. Analyst consensus is a $15.00 price target with a Hold-heavy rating distribution.
The stock presents a value opportunity with low P/E and P/S ratios, but significant risks include persistent net losses, high debt levels, and competitive pressures in the EV transition. Upside depends on execution of cost controls and successful new product launches, particularly in electric vehicles.
Trailing returns across standard periods
Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.
Read more on ENVB →Ford Motor Company designs, manufactures, and services cars and trucks. The Company also provides vehicle-related financing, leasing, and insurance through its subsidiary.
Read more on F →